论文部分内容阅读
临床上经常遇到结核病(TB)合并丙型肝炎病毒(HCV)感染者需要同时治疗。当抗HCV和抗TB药物联用时需要考虑药物-药物之间的相互作用(DDIs)、抗TB药物诱导的肝毒性,以及肝脏疾病状态。现重点讨论常用抗TB和抗HCV药物的代谢机制和联用药物的选择,为TB合并HCV感染患者提供合理的用药选择。“,”Clinically, patients with tuberculosis (TB) combined with hepatitis C virus (HCV) infection often require simultaneous treatment. Consequently, when anti-HCV and TB drugs are used in combination drug-drug interactions (DDIs), anti-TB drug-induced hepatotoxicity, and liver disease states need to be considered. This paper focuses on discussing the metabolic mechanisms of commonly used anti-TB and HCV drugs and the selection options of combined drugs, so as to provide rational drug use for TB patients combined with HCV infection.